Research and Clinical Trials

Title: Roche BN29552
Brief Description: This study is to evaluate the safety and efficacy of crenezumab as compared with placebo in patients with prodromal to mild Alzheimer's Disease.
Who may be Eligible: Male or female 50-85 years old with Alzheimer's disease diagnosis
Start Date: 04/15/2016
IRB Number: 04-16-01A
Principal Investigator: Tcheremissine, Oleg
Contact Name: Dineen